It’s willing to pay US$44bil for Genentech shares
BASEL: Swiss drugmaker Roche Holding AG offered to acquire all outstanding shares in its US partner Genentech Inc for US$43.7bil in cash to reinforce its position in cancer medicine.
It’s willing to pay US$44bil for Genentech shares
BASEL: Swiss drugmaker Roche Holding AG offered to acquire all outstanding shares in its US partner Genentech Inc for US$43.7bil in cash to reinforce its position in cancer medicine.